|
Asensi-Canto A, Rodriguez-Braun E, Beltran-Videla A, Hurtado AM, Conesa-Zamora P. Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial. Front Oncol. 2023 Sep 29;13:1238464. doi: 10.3389/fonc.2023.1238464. eCollection 2023. Erratum In: Front Oncol. 2024 Apr 16;14:1405306. doi: 10.3389/fonc.2024.1405306. PubMed PMID: 37841433; PubMed Central PMCID: PMC10570506.
AÑO: 2023; IF: 3.5
|
37841433
|
Feliciangeli E, Albaladejo-Gonzalez A, Garcia-Rodriguez J, Lazaro-Sanchez A, Borg R, Pimentel-Caceres P, Soriano-Polo D, Rodriguez-Braun E, Balsalobre-Yago J, Martinez-Ortiz MJ, Wikstrom-Fernandez S, Murillo-Herrera A, Garcia-Garcia T, Garcia-Solano J, Conesa-Zamora P, Luengo-Gil G. Clinical and immunopathological evaluation and its comparison with IHC consensus molecular subtypes of colorectal cancer. Sci Rep. 2025 Jul 1;15(1):21626. doi: 10.1038/s41598-025-04962-w. PubMed PMID: 40594059.
AÑO: 2025; IF: 3.9
|